Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Federal government cracks down on international student visas, NextEd foresees difficulties
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Federal government cracks down on international student visas, NextEd foresees difficulties
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Federal government cracks down on international student visas, NextEd foresees difficulties
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Federal government cracks down on international student visas, NextEd foresees difficulties
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Federal government cracks down on international student visas, NextEd foresees difficulties
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Refurbished tech pivot gathers momentum as Harris Technology’s margins expand and cash flow turns positive
    Refurbished tech pivot gathers momentum as Harris Technology’s margins expand and cash flow turns positive
    • News

  • Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    • News

  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium
    Harris Technology secures major investment from Taiwan's FSP Technology at 100% premium
    • News

  • Spacetalk enters New Zealand retail market with child smartwatches that limit browsing access to illicit content
    • News

    Spacetalk enters New Zealand retail market with child smartwatches that limit browsing access to illicit content

    Parents in New Zealand will soon be able to get their hands on cutting-edge technology designed for child safety with tech company Spacetalk (ASX: SPA) signing a partnership agreement with New Zealand-based retailer, The Warehouse Group NZ, to have their smartwatch products sold in 145 stores.  The Adventurer 2 and Spacetalk Loop smartwatches are designed

    Read More
    Public
  • Just can’t debt enough: Pioneer acquires debt portfolio from Panthera for $24.1 million
    • News

    Just can’t debt enough: Pioneer acquires debt portfolio from Panthera for $24.1 million

    When debt goes unpaid for too long, even banks and major financial institutions need to get some help on board. That’s when financial services like Pioneer (ASX: PNC) come to the fore, promising to recover that debt while keeping customers’ financial needs in mind.  Australian debt recovery specialist Pioneer has acquired a Debt Portfolio from

    Read More
    Public
  • Imagion Biosystems’ cancer tumour detection tech produces early positive results
    • News

    Imagion Biosystems’ cancer tumour detection tech produces early positive results

    In 2023, cancer is responsible for about three in 10 deaths across Australia. And among women, breast cancer remains the most commonly diagnosed. Over two million women worldwide are diagnosed with breast cancer annually, and approximately 20% of them are diagnosed with HER2+ (human epidermal growth factor receptor 2) breast cancer. The growing ageing population

    Read More
    Public
  • Wisr fourth ABS transaction to free up cost of funding, signals investor confidence following both Nantes departures
    • News

    Wisr fourth ABS transaction to free up cost of funding, signals investor confidence following both Nantes departures

    After ousting Anthony Nantes as CEO in August 2023 (and subsequently seeing John Nantes depart as Chairman), consumer lending company Wisr (ASX: WZR) has been on a cost management journey, trying to regain shareholders’ faith.  In the face of its declining loan book balance and revenue, the Company has established the pricing for its fourth

    Read More
    Public
  • Little Green Pharma to target growing medicinal cannabis market thanks to legal changes
    • News

    Little Green Pharma to target growing medicinal cannabis market thanks to legal changes

    A healthcare policy change passed in France is likely to see the country quickly targeted by medicinal cannabis companies with Little Green Pharma (ASX: LGP) quick to confirm their plans to increase product distribution to the country thanks to newly favourable healthcare legislation.  The recent amendment to the Projet de loi de financement de la

    Read More
    Public
  • Dovish Fed comments and weak economic data provide a boost to markets | Monthly Wrap
    • News

    Dovish Fed comments and weak economic data provide a boost to markets | Monthly Wrap

    Global Markets Update US markets: US markets were stronger, with the Dow Jones up +8.8% and S&P500 up +8.9%, as dovish comments from several Fed officials following weak economic data saw swaps pricing in a 50% chance of a U.S. rate cut in March with the effective fed funds rate to fall to about 4.06%

    Read More
    Public
  • IOUpay reports $36m in losses amid legal battles against former Board for alleged misappropriation of funds
    • News

    IOUpay reports $36m in losses amid legal battles against former Board for alleged misappropriation of funds

    Haven’t heard of the company IOUPay (ASX: IOU) in a while? You’re probably not alone because their shares have been suspended from trading since March 2023 while the new Board of Directors attempt to unravel the utter mess left to them from the previous Board, and it’s cost them $36 million according to the FY23

    Read More
    Public
  • AVA Risk secures critical surveillance contract with Sydney Trains for train yards security
    • News

    AVA Risk secures critical surveillance contract with Sydney Trains for train yards security

    In a strategic move to fortify the security infrastructure of Sydney Trains, Ava Risk Group (ASX: AVA) has inked a five-year support agreement to enhance the safety of vital transportation assets with intrusion detection technology.  The contract is valued at approximately $500k and is an extension of the existing contract Ava has had in place

    Read More
    Public
  • UNITH delivers eSocial Worker for public health services across 14 countries
    • News

    UNITH delivers eSocial Worker for public health services across 14 countries

    Access to high quality medical advice 24/7 will soon be launched in 14 European countries by the Alliance for Public Health (APH) which has delivered its digital human social worker from artificial intelligence company UNITH (ASX: UNT), specialists in AI solutions.  The eSocial Worker, is the AI solution sought by APH which issued a public

    Read More
    Public
  • Cyclopharm makes US entry with Duke University Hospital the first contract for Technegas
    • News

    Cyclopharm makes US entry with Duke University Hospital the first contract for Technegas

    After gaining US FDA approval in September 2023, nuclear medicine company Cyclopharm (ASX: CYC) has made an official entry into the country with the signing of its inaugural commercial contract for Technegas in the United States with Duke University Hospital the first institution to enter into a formal agreement to use Technegas. Technegas, an imaging

    Read More
    Public
  • «
  • ‹
  • 66
  • 67
  • 68
  • 69
  • 70
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.